Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GILTERITINIB vs GLIMEPIRIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GILTERITINIB vs GLIMEPIRIDE: Safety Overview

Metric GILTERITINIB GLIMEPIRIDE
Total FAERS Reports 3,672 5,572
Deaths Reported 1,014 552
Death Rate 27.6% 9.9%
Hospitalizations 1,407 2,550
Average Patient Age 60.8 yrs 66.6 yrs
% Female Patients 48.5% 46.4%
FDA Approval Date Nov 28, 2018 Apr 17, 2013
Manufacturer Astellas Pharma US, Inc. A-S Medication Solutions
Route ORAL ORAL
Marketing Status Prescription Discontinued